Šafer, M.; Feldi, I.; Šahinović, I.; Tolj, I.; Pirić, M.; Šojat, D.; Oštarijaš, E.; Mihaljević, D.
Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study. Medicina 2025, 61, 991.
https://doi.org/10.3390/medicina61060991
AMA Style
Šafer M, Feldi I, Šahinović I, Tolj I, Pirić M, Šojat D, Oštarijaš E, Mihaljević D.
Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study. Medicina. 2025; 61(6):991.
https://doi.org/10.3390/medicina61060991
Chicago/Turabian Style
Šafer, Mario, Ivan Feldi, Ines Šahinović, Ivana Tolj, Marko Pirić, Dunja Šojat, Eduard Oštarijaš, and Dubravka Mihaljević.
2025. "Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study" Medicina 61, no. 6: 991.
https://doi.org/10.3390/medicina61060991
APA Style
Šafer, M., Feldi, I., Šahinović, I., Tolj, I., Pirić, M., Šojat, D., Oštarijaš, E., & Mihaljević, D.
(2025). Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study. Medicina, 61(6), 991.
https://doi.org/10.3390/medicina61060991